|1||NCT03620643||Recruiting||ROS1 Targeting With Crizotinib in Advanced E-cadherin Negative, ER Positive Lobular Breast Cancer or Diffuse Gastric Cancer Study||
||Other / Industry||
||58||All||18 Years and older (Adult, Older Adult)||NCT03620643||CCR4684||ROLo||May 9, 2019||December 4, 2020||April 4, 2022||August 8, 2018||June 3, 2019||
|A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung||
||343||All||18 Years and older (Adult, Older Adult)||NCT01154140||A8081014
|PROFILE 1014||January 13, 2011||November 30, 2013||November 30, 2016||June 30, 2010||November 6, 2017||January 5, 2015||
† Study has passed its completion date and status has not been verified in more than two years.